These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27993853)

  • 21. Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078/126 isolates of human and animal origin.
    Álvarez-Pérez S; Blanco JL; Harmanus C; Kuijper E; García ME
    Vet Microbiol; 2017 Feb; 199():15-22. PubMed ID: 28110780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
    Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
    López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
    Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.
    Solomon K; Fanning S; McDermott S; Murray S; Scott L; Martin A; Skally M; Burns K; Kuijper E; Fitzpatrick F; Fenelon L; Kyne L
    J Antimicrob Chemother; 2011 Sep; 66(9):1976-82. PubMed ID: 21712239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden.
    Rashid MU; Lozano HM; Weintraub A; Nord CE
    Anaerobe; 2013 Apr; 20():32-5. PubMed ID: 23454525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection.
    Chilton CH; Crowther GS; Baines SD; Todhunter SL; Freeman J; Locher HH; Athanasiou A; Wilcox MH
    J Antimicrob Chemother; 2014 Mar; 69(3):697-705. PubMed ID: 24128668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil.
    Alcides AP; Brazier JS; Pinto LJ; Balassiano IT; Boente RF; de Paula GR; Ferreira EO; Avelar KE; Miranda KR; Ferreira MC; Domingues RM
    Antonie Van Leeuwenhoek; 2007 Jul; 92(1):53-9. PubMed ID: 17252315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic profiling of Clostridium difficile ribotype 176--A multidrug resistant relative to C. difficile ribotype 027.
    Krutova M; Matejkova J; Tkadlec J; Nyc O
    Anaerobe; 2015 Dec; 36():88-90. PubMed ID: 26256807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin.
    Knight DR; Riley TV
    J Antimicrob Chemother; 2016 Aug; 71(8):2213-7. PubMed ID: 27130808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile isolates with high linezolid MICs harbor the multiresistance gene cfr.
    Marín M; Martín A; Alcalá L; Cercenado E; Iglesias C; Reigadas E; Bouza E
    Antimicrob Agents Chemother; 2015 Jan; 59(1):586-9. PubMed ID: 25385106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106.
    Ratnayake L; McEwen J; Henderson N; Nathwani D; Phillips G; Brown D; Coia J
    J Hosp Infect; 2011 Nov; 79(3):242-7. PubMed ID: 21864938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxigenic Clostridium difficile PCR ribotypes in edible marine bivalve molluscs in Italy.
    Troiano T; Harmanus C; Sanders IM; Pasquale V; Dumontet S; Capuano F; Romano V; Kuijper EJ
    Int J Food Microbiol; 2015 Sep; 208():30-4. PubMed ID: 26022983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013-2015.
    Karlowsky JA; Adam HJ; Kosowan T; Baxter MR; Nichol KA; Laing NM; Golding G; Zhanel GG
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):105-111. PubMed ID: 29456070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of swine isolates of Clostridium difficile in Spain: a potential source of epidemic multidrug resistant strains?
    Peláez T; Alcalá L; Blanco JL; Álvarez-Pérez S; Marín M; Martín-López A; Catalán P; Reigadas E; García ME; Bouza E
    Anaerobe; 2013 Aug; 22():45-9. PubMed ID: 23764416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
    Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain.
    Arca-Suárez J; Galán-Sánchez F; Cano-Cano F; García-Santos G; Rodríguez-Iglesias MA
    Anaerobe; 2018 Dec; 54():146-150. PubMed ID: 30261271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
    Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
    Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.
    Krutova M; Nyc O; Matejkova J; Kuijper EJ; Jalava J; Mentula S
    J Microbiol Immunol Infect; 2018 Jun; 51(3):344-351. PubMed ID: 28583353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia.
    Mackin KE; Elliott B; Kotsanas D; Howden BP; Carter GP; Korman TM; Riley TV; Rood JI; Jenkin GA; Lyras D
    Anaerobe; 2015 Aug; 34():80-3. PubMed ID: 25944720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-kill kinetics of cadazolid and comparator antibacterial agents against different ribotypes of Clostridium difficile.
    Skinner K; Birchall S; Corbett D; Thommes P; Locher HH
    J Med Microbiol; 2018 Sep; 67(9):1402-1409. PubMed ID: 30052178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.